TN2013000141A1 - Substituted n-(2-arylamino) aryl sulfonamide-containing combinations - Google Patents

Substituted n-(2-arylamino) aryl sulfonamide-containing combinations

Info

Publication number
TN2013000141A1
TN2013000141A1 TNP2013000141A TN2013000141A TN2013000141A1 TN 2013000141 A1 TN2013000141 A1 TN 2013000141A1 TN P2013000141 A TNP2013000141 A TN P2013000141A TN 2013000141 A TN2013000141 A TN 2013000141A TN 2013000141 A1 TN2013000141 A1 TN 2013000141A1
Authority
TN
Tunisia
Prior art keywords
component
arylamino
combinations
aryl sulfonamide
substituted
Prior art date
Application number
TNP2013000141A
Other languages
French (fr)
Inventor
Florian Puhler
Marion Hitchcock
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/067041 external-priority patent/WO2012041987A1/en
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of TN2013000141A1 publication Critical patent/TN2013000141A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to : * combinations of : component A : one or more omega-carboxyaryl-substituted diphenyl urea compounds of general formula (I), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; component B : one or more N-(2-arylamino) aryl sulfonamide compounds of general formula (II), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; and, optionally, component C : one or more further pharmaceutical agents; in which optionally some or all of the components are in the form of a pharmaceutical formulation which is ready for use to be administered simultaneously, concurrently, separately or sequentially. dependently of one another by the oral, intravenous, topical, local installations, intraperitoneal or nasal route; * use of such combinations for the preparation of a medicament for the treatment or prophylaxis of a cancer; and * a kit comprising such a combination.
TNP2013000141A 2011-09-29 2013-03-29 Substituted n-(2-arylamino) aryl sulfonamide-containing combinations TN2013000141A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/067041 WO2012041987A1 (en) 2010-10-01 2011-09-29 Substituted n-(2-arylamino)aryl sulfonamide-containing combinations

Publications (1)

Publication Number Publication Date
TN2013000141A1 true TN2013000141A1 (en) 2014-06-25

Family

ID=54360806

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000141A TN2013000141A1 (en) 2011-09-29 2013-03-29 Substituted n-(2-arylamino) aryl sulfonamide-containing combinations

Country Status (1)

Country Link
TN (1) TN2013000141A1 (en)

Similar Documents

Publication Publication Date Title
MX2013003695A (en) Substituted n-(2-arylamino)aryl sulfonamide-containing combinations.
TN2012000493A1 (en) Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations
CY1124882T1 (en) 1,4-DI-CONSTITUTED PYRIDAZINE ANALOGUES AND METHODS FOR THERAPEUTIC TREATMENT OF CONDITIONS RELATED TO SMN DEFICIENCY
CY1119490T1 (en) PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT
UA109698C2 (en) AZAINDASOL OR DIAZAINDASOL DERIVATIVES AS A MEDICINE
EA201591195A1 (en) NEW QUINOLON DERIVATIVES
EA201201680A1 (en) MORFOLINOPYRIMIDINES AND THEIR APPLICATION IN THERAPY
EA202090860A1 (en) THIADIAZOL ANALOGUES AND METHODS FOR TREATMENT OF CONDITIONS RELATED TO SMN DEFICIENCY
EA201490864A1 (en) DERIVATIVES (4-PHENYLIMIDAZOL-2-IL) ETYLAMINE AS SODIUM CHANNEL MODULATORS
EA201490471A1 (en) PYRIDAZINOUS COMPOUNDS AND THEIR APPLICATION AS DAAO INHIBITORS
EA201400358A1 (en) SUBSTITUTED N- [1-CYANO-2- (PHENYL) ETHYL] -2-AZABICYCLO [2.2.1] HEPTAN-3-CARBOXAMIDE INHIBITORS KATEPSIN C
EA201391018A1 (en) PREPARATIONS OF IMMUNOSUPRESSANTS
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
AR086800A1 (en) TOPICA OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
EA201391524A1 (en) GLYCOSIDE DERIVATIVES AND THEIR APPLICATION
EA201490573A1 (en) CONTAINING BENZOTHIAZOLONE
IN2014KN01113A (en)
EA201390488A1 (en) NEW GPR 119 AGONISTS
TN2013000141A1 (en) Substituted n-(2-arylamino) aryl sulfonamide-containing combinations
AR086876A1 (en) SULFONAMIDE HETEROCICLIC DERIVATIVES
UA111851C2 (en) PIRIDASINONE COMPOUNDS AND THEIR USE AS DAAO INHIBITORS
TN2014000077A1 (en) Pyridazinone compounds and their use as daao inhibitors